Objectives: To prospectively study all patients with COPD and spontaneous pneumothorax (SP) who underwent thoracoscopic talc poudrage (TP) under local anesthesia to determine its efficacy and safety in recurrence prevention.
Methods: Data on clinical measurements, complications, duration of chest tube drainage, length of hospital stay, and outcome were collected.
Results: Forty-one patients (38 men and 3 women) with a mean (+/- SD) age of 70.7 +/- 7.2 years were treated. All patients had COPD, with a mean FEV(1) of 41 +/- 14% predicted. The majority of SPs measured 20 to 50% in size, and 34% were recurrent. Three grams of talc were insufflated into the pleural cavity without complications. Thirteen patients (32%) complained of pain, 5 (12%) developed fever, 27 (66%) had subcutaneous emphysema, and 7 (17%) had prolonged air leaks. Postoperative chest tube drainage and hospital stay were 4 and 5 days, respectively. Success was 95% after a median follow-up of 35 months. Four patients with FEV(1) of < 40% predicted died within 30 days of the procedure, yielding a mortality rate of 10%. FEV(1) (in liters), FEV(1) (in % predicted), and ischemic heart disease were risk factors that influenced early mortality.
Conclusion: Thoracoscopic TP is effective for pneumothorax prevention and can be performed with acceptable mortality in patients with advanced COPD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1378/chest.125.4.1315 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Malignant Pleural Effusion: Diagnosis and Treatment-Up-to-Date Perspective.
Curr Oncol
November 2024
Department of Thoracic Surgery, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
Malignant pleural effusion is the presence of malignant cells within the pleural fluid, representing the second most common cause of pleural exudate. Although diagnostic methods and management techniques for malignant pleural effusion have dramatically improved over the decades, the current treatment is still palliative, aiming to remove pleural fluid, possibly prevent its recurrence, and alleviate symptoms through a wide range of available procedures. Treatment should be tailored to the individual patient, considering comorbidities, size of the effusion, rate of fluid accumulation, underlying cardiac or respiratory conditions, rate of recurrence, presence of loculations or trapped lung, tumor characteristics, cancer type, and patient preferences.
View Article and Find Full Text PDFThe evolving role of medical thoracoscopy on therapeutic management of pleural disease.
Curr Opin Pulm Med
January 2025
Division of Respiratory and Critical Care Medicine. Department of Medicine, National University Hospital, Singapore.
Article Synopsis
- Medical thoracoscopy (MT) is a less invasive procedure widely accepted for diagnosing and managing pleural diseases, offering advantages for patients who cannot undergo general anesthesia.
- Recent advancements include new techniques for identifying malignant pleural effusions and the potential benefits of combining MT with talc poudrage and pleural catheter insertion to reduce hospital stays.
- The review discusses MT's role in treating a range of conditions beyond malignant effusions, including pneumothorax and pleural infections, highlighting its benefits and drawbacks compared to traditional methods for better clinical decision-making.
The role of day-case thoracoscopy at a district general hospital: A real world observational study.
Future Healthc J
September 2024
Department of Respiratory Medicine, Kettering General Hospital, Kettering General Hospital NHS Trust, UK.
Objective: To assess the feasibility and safety of talc pleurodesis performed as part of day-case medical thoracoscopy.
Methods: A Richard Wolf® 5 mm mini thoracoscope through a 5.5 mm port was used with eligible cases having talc poudrage followed by insertion of indwelling pleural catheter (IPC).
Talc slurry versus thoracoscopic talc insufflation for malignant pleural effusion: a systematic review and meta-analysis.
J Bras Pneumol
August 2024
. Divisão de Cirurgia Torácica, Instituto do Coração - InCor - Universidade de São Paulo (SP) São Paulo Brasil.
Objective: Talc pleurodesis is a widely used treatment option for malignant pleural effusion (MPE). However, the optimal form of administration remains controversial. Thus, we performed a systematic review and meta-analysis to assess the effectiveness of talc slurry (TS) in comparison with thoracoscopic talc insufflation/poudrage (TTI) for MPE treatment.
View Article and Find Full Text PDFThe Role of Medical Thoracoscopy with Talc Poudrage in Spontaneous, Iatrogenic, and Traumatic Pneumothorax: A Prolonged Experience of a Tertiary Care Center.
Pulm Ther
September 2024
Department of Pulmonology, Santa Maria della Misericordia University Hospital, Via Colugna, 33100, Udine, Italy.
Article Synopsis
- - Medical thoracoscopy is a safe, minimally invasive procedure primarily used for treating unexplained exudative pleural effusions, but it can also be utilized for pneumothorax (PNX).
- - A study of 95 patients with various types of PNX showed that those who received at least 4 grams of talc had a significantly lower risk of needing further procedures and experienced less recurrence over two years.
- - The results indicate that medical thoracoscopy is effective for acute PNX treatment with potential for long-term success, but further large-scale studies are necessary to solidify its role in clinical practice.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!